Matt Taylor is a senior process development associate at KBI Biopharma, where he focuses on the design, optimization, and scale-up of purification processes for biopharmaceutical manufacturing. Matt ...
A recent study published in Nature Microbiology identified a monoclonal antibody (mAb) neutralizing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variants. Study: ...
Monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) are the fastest growing class of therapeutic agents. There are nearly 50 mAb-related products approved by the U.S. FDA and the European ...
FARGO, North Dakota & SALT LAKE CITY, Utah--(BUSINESS WIRE)--Genovac, a leading contract research and manufacturing organization (CRO/CMO) that discovers, develops, and manufactures antibodies for ...
Increased expression of B7-H3 has been previously reported in multiple solid tumors, including pancreatic cancer. In a recent article, researchers from the University of Tuebingen discussed the ...
When therapeutic proteins form aggregates, they can limit clinical effectiveness and possibly provoke a serious immunogenic response. Thermostability screening by way of a temperature ramp is a ...
Osteosarcomas (OS) are the most common malignant bone tumor. The disease originates within the fastest growing areas of the long bones of children and young adults, where the histologic hallmark of OS ...